China Atracurium Market Report & Forecast 2021-2027

Publisher Name :
Date: 18-Oct-2021
No. of pages: 92
Inquire Before Buying

China Atracurium Market, By Type, 2016-2021, 2022-2027 ($ Millions) & (K Pcs)

China Atracurium Market Segment Percentages, By Type, 2020 (%)

- 25mg

- 50mg

China Atracurium Market, By Application, 2016-2021, 2022-2027 ($ Millions) & (K Pcs)

China Atracurium Market Segment Percentages, By Application, 2020 (%)

- Hospital

- Clinic

- ASCs

- Others

Competitor Analysis

The report also provides analysis of leading market participants including:

Key companies Atracurium revenues in China market, 2016-2021 (Estimated), ($ millions)

Key companies Atracurium revenues share in China market, 2020 (%)

Key companies Atracurium sales in China market, 2016-2021 (Estimated), (K Pcs)

Key companies Atracurium sales share in China market, 2020 (%)

Further, the report presents profiles of competitors in the market, key players include:

- GSK

- HOSPIRA

- Dongying (Jiangsu) Pharmaceutical

- Jiangsu Hengrui Medicine

- Zhejiang Xianju Pharmaceutical

- Joshi & Company

- ZHEJIANG HAISEN PHARMACEUICAL

China Atracurium Market Report & Forecast 2021-2027

Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Atracurium Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 China Atracurium Market Overview
1.4 Methodology & Sources of Information
1.4.1 Research Methodology
1.4.2 Research Process
1.4.3 Base Year
2 China Atracurium Overall Market Size
2.1 China Atracurium Market Size: 2021 VS 2027
2.2 China Atracurium Revenue, Prospects & Forecasts: 2016-2027
2.3 China Atracurium Sales: 2016-2027
3 Company Landscape
3.1 Top Atracurium Players in China Market
3.2 Top China Atracurium Companies Ranked by Revenue
3.3 China Atracurium Revenue by Companies
3.4 China Atracurium Sales by Companies
3.5 China Atracurium Price by Manufacturer (2016-2021)
3.6 Top 3 and Top 5 Atracurium Companies in China Market, by Revenue in 2020
3.7 Manufacturers Atracurium Product Type
3.8 Tier 1, Tier 2 and Tier 3 Atracurium Players in China Market
3.8.1 List of Tier 1 Atracurium Companies in China
3.8.2 List of Tier 2 and Tier 3 Atracurium Companies in China
4 Sights by Type
4.1 Overview
4.1.1 By Type - China Atracurium Market Size Markets, 2021 & 2027
4.1.2 25mg
4.1.3 50mg
4.2 By Type - China Atracurium Revenue & Forecasts
4.2.1 By Type - China Atracurium Revenue, 2016-2021
4.2.2 By Type - China Atracurium Revenue, 2022-2027
4.2.3 By Type - China Atracurium Revenue Market Share, 2016-2027
4.3 By Type - China Atracurium Sales & Forecasts
4.3.1 By Type - China Atracurium Sales, 2016-2021
4.3.2 By Type - China Atracurium Sales, 2022-2027
4.3.3 By Type - China Atracurium Sales Market Share, 2016-2027
4.4 By Type - China Atracurium Price (Manufacturers Selling Prices), 2016-2027
5 Sights by Application
5.1 Overview
5.1.1 By Application - China Atracurium Market Size, 2021 & 2027
5.1.2 Hospital
5.1.3 Clinic
5.1.4 ASCs
5.1.5 Others
5.2 By Application - China Atracurium Revenue & Forecasts
5.2.1 By Application - China Atracurium Revenue, 2016-2021
5.2.2 By Application - China Atracurium Revenue, 2022-2027
5.2.3 By Application - China Atracurium Revenue Market Share, 2016-2027
5.3 By Application - China Atracurium Sales & Forecasts
5.3.1 By Application - China Atracurium Sales, 2016-2021
5.3.2 By Application - China Atracurium Sales, 2022-2027
5.3.3 By Application - China Atracurium Sales Market Share, 2016-2027
5.4 By Application - China Atracurium Price (Manufacturers Selling Prices), 2016-2027
6 Manufacturers & Brands Profiles
6.1 GSK
6.1.1 GSK Corporation Information
6.1.2 GSK Overview
6.1.3 GSK Atracurium Sales and Revenue in China Market (2016-2021)
6.1.4 GSK Atracurium Product Description
6.1.5 GSK Recent Developments
6.2 HOSPIRA
6.2.1 HOSPIRA Corporation Information
6.2.2 HOSPIRA Overview
6.2.3 HOSPIRA Atracurium Sales and Revenue in China Market (2016-2021)
6.2.4 HOSPIRA Atracurium Product Description
6.2.5 HOSPIRA Recent Developments
6.3 Dongying (Jiangsu) Pharmaceutical
6.3.1 Dongying (Jiangsu) Pharmaceutical Corporation Information
6.3.2 Dongying (Jiangsu) Pharmaceutical Overview
6.3.3 Dongying (Jiangsu) Pharmaceutical Atracurium Sales and Revenue in China Market (2016-2021)
6.3.4 Dongying (Jiangsu) Pharmaceutical Atracurium Product Description
6.3.5 Dongying (Jiangsu) Pharmaceutical Recent Developments
6.4 Jiangsu Hengrui Medicine
6.4.1 Jiangsu Hengrui Medicine Corporation Information
6.4.2 Jiangsu Hengrui Medicine Overview
6.4.3 Jiangsu Hengrui Medicine Atracurium Sales and Revenue in China Market (2016-2021)
6.4.4 Jiangsu Hengrui Medicine Atracurium Product Description
6.4.5 Jiangsu Hengrui Medicine Recent Developments
6.5 Zhejiang Xianju Pharmaceutical
6.5.1 Zhejiang Xianju Pharmaceutical Corporation Information
6.5.2 Zhejiang Xianju Pharmaceutical Overview
6.5.3 Zhejiang Xianju Pharmaceutical Atracurium Sales and Revenue in China Market (2016-2021)
6.5.4 Zhejiang Xianju Pharmaceutical Atracurium Product Description
6.5.5 Zhejiang Xianju Pharmaceutical Recent Developments
6.6 Joshi & Company
6.6.1 Joshi & Company Corporation Information
6.6.2 Joshi & Company Overview
6.6.3 Joshi & Company Atracurium Sales and Revenue in China Market (2016-2021)
6.6.4 Joshi & Company Atracurium Product Description
6.6.5 Joshi & Company Recent Developments
6.7 ZHEJIANG HAISEN PHARMACEUICAL
6.7.1 ZHEJIANG HAISEN PHARMACEUICAL Corporation Information
6.7.2 ZHEJIANG HAISEN PHARMACEUICAL Overview
6.7.3 ZHEJIANG HAISEN PHARMACEUICAL Atracurium Sales and Revenue in China Market (2016-2021)
6.7.4 ZHEJIANG HAISEN PHARMACEUICAL Atracurium Product Description
6.7.5 ZHEJIANG HAISEN PHARMACEUICAL Recent Developments
7 China Atracurium Production Capacity, Analysis
7.1 China Atracurium Production Capacity, 2016-2027
7.2 Atracurium Production Capacity of Key Manufacturers in China Market
8 Key Market Trends, Opportunity, Drivers and Restraints
8.1 Market Opportunities & Trends
8.2 Market Drivers
8.3 Market Restraints
9 Atracurium Supply Chain Analysis
9.1 Atracurium Industry Value Chain
9.2 Atracurium Upstream Market
9.3 Atracurium Downstream and Clients
9.4 Marketing Channels Analysis
9.4.1 Marketing Channels
9.4.2 Atracurium Distributors and Sales Agents in China Market
10 Conclusion
11 Appendix
11.1 Note
11.2 Examples of Clients
11.3 Author Details
11.4 Disclaimer
List of Tables
Table 1. Key Players of Atracurium in China Market
Table 2. Top Atracurium Players in China Market, Ranking by Revenue (2019)
Table 3. China Atracurium Revenue by Companies, (US$, Mn), 2016-2021
Table 4. China Atracurium Revenue Share by Companies, 2016-2021
Table 5. China Atracurium Sales by Companies, (K Pcs), 2016-2021
Table 6. China Atracurium Sales Share by Companies, 2016-2021
Table 7. Key Manufacturers Atracurium Price (2016-2021) & (USD/Pcs)
Table 8. Manufacturers Atracurium Product Type
Table 9. List of Tier 1 Atracurium Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 10. List of Tier 2 and Tier 3 Atracurium Companies, Revenue (US$, Mn) in 2020 and Market Share
Table 11. Major Manufacturers of 25mg
Table 12. Major Manufacturers of 50mg
Table 13. By Type - China Atracurium Revenue, (US$, Mn), 2021 & 2027
Table 14. By Type - China Atracurium Revenue (US$, Mn), 2016-2021
Table 15. By Type - China Atracurium Revenue (US$, Mn), 2022-2027
Table 16. By Type - China Atracurium Sales (K Pcs), 2016-2021
Table 17. By Type - China Atracurium Sales (K Pcs), 2022-2027
Table 18. By Application - China Atracurium Revenue, (US$, Mn), 2021 VS 2027
Table 19. By Application - China Atracurium Revenue (US$, Mn), 2016-2021
Table 20. By Application - China Atracurium Revenue (US$, Mn), 2022-2027
Table 21. By Application - China Atracurium Sales (K Pcs), 2016-2021
Table 22. By Application - China Atracurium Sales (K Pcs), 2022-2027
Table 23. GSK Corporation Information
Table 24. GSK Description and Major Businesses
Table 25. GSK Atracurium Sales (K Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pcs) (2016-2021)
Table 26. GSK Atracurium Product
Table 27. GSK Recent Developments
Table 28. HOSPIRA Corporation Information
Table 29. HOSPIRA Description and Major Businesses
Table 30. HOSPIRA Atracurium Sales (K Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pcs) (2016-2021)
Table 31. HOSPIRA Atracurium Product
Table 32. HOSPIRA Recent Developments
Table 33. Dongying (Jiangsu) Pharmaceutical Corporation Information
Table 34. Dongying (Jiangsu) Pharmaceutical Description and Major Businesses
Table 35. Dongying (Jiangsu) Pharmaceutical Atracurium Sales (K Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pcs) (2016-2021)
Table 36. Dongying (Jiangsu) Pharmaceutical Atracurium Product
Table 37. Dongying (Jiangsu) Pharmaceutical Recent Developments
Table 38. Jiangsu Hengrui Medicine Corporation Information
Table 39. Jiangsu Hengrui Medicine Description and Major Businesses
Table 40. Jiangsu Hengrui Medicine Atracurium Sales (K Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pcs) (2016-2021)
Table 41. Jiangsu Hengrui Medicine Atracurium Product
Table 42. Jiangsu Hengrui Medicine Recent Developments
Table 43. Zhejiang Xianju Pharmaceutical Corporation Information
Table 44. Zhejiang Xianju Pharmaceutical Description and Major Businesses
Table 45. Zhejiang Xianju Pharmaceutical Atracurium Sales (K Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pcs) (2016-2021)
Table 46. Zhejiang Xianju Pharmaceutical Atracurium Product
Table 47. Zhejiang Xianju Pharmaceutical Recent Developments
Table 48. Joshi & Company Corporation Information
Table 49. Joshi & Company Description and Major Businesses
Table 50. Joshi & Company Atracurium Sales (K Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pcs) (2016-2021)
Table 51. Joshi & Company Atracurium Product
Table 52. Joshi & Company Recent Developments
Table 53. ZHEJIANG HAISEN PHARMACEUICAL Corporation Information
Table 54. ZHEJIANG HAISEN PHARMACEUICAL Description and Major Businesses
Table 55. ZHEJIANG HAISEN PHARMACEUICAL Atracurium Sales (K Pcs), Revenue (US$, Mn) and Gross Margin (USD/Pcs) (2016-2021)
Table 56. ZHEJIANG HAISEN PHARMACEUICAL Atracurium Product
Table 57. ZHEJIANG HAISEN PHARMACEUICAL Recent Developments
Table 58. Atracurium Production Capacity (K Pcs) of Key Manufacturers in China Market, 2019-2021 (K Pcs)
Table 59. China Atracurium Capacity Market Share of Key Manufacturers, 2019-2021
Table 60. Atracurium Market Opportunities & Trends in China Market
Table 61. Atracurium Market Drivers in China Market
Table 62. Atracurium Market Restraints in China Market
Table 63. Atracurium Raw Materials
Table 64. Atracurium Raw Materials Suppliers in China Market
Table 65. Typical Atracurium Downstream
Table 66. Atracurium Downstream Clients in China Market
Table 67. Atracurium Distributors and Sales Agents in China Market
List of Figures
Figure 1. Atracurium Product Picture
Figure 2. Atracurium Segment by Type
Figure 3. Atracurium Segment by Application
Figure 4. China Atracurium Market Overview: 2020
Figure 5. China Atracurium Market Size: 2021 VS 2027 (US$, Mn)
Figure 6. China Atracurium Revenue, 2016-2027 (US$, Mn)
Figure 7. Atracurium Sales in China Market: 2016-2027 (K Pcs)
Figure 8. The Top 3 and 5 Players Market Share by Atracurium Revenue in 2020
Figure 9. 25mg Product Picture
Figure 10. 50mg Product Picture
Figure 11. By Type - China Atracurium Sales Market Share, 2016-2027
Figure 12. By Type - China Atracurium Revenue Market Share, 2016-2027
Figure 13. By Type - China Atracurium Price (USD/Pcs), 2016-2027
Figure 14. Hospital
Figure 15. Clinic
Figure 16. ASCs
Figure 17. Others
Figure 18. By Application - China Atracurium Sales Market Share, 2016-2027
Figure 19. By Application - China Atracurium Revenue Market Share, 2016-2027
Figure 20. By Application - China Atracurium Price (USD/Pcs), 2016-2027
Figure 21. GSK Atracurium Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 22. HOSPIRA Atracurium Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 23. Dongying (Jiangsu) Pharmaceutical Atracurium Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 24. Jiangsu Hengrui Medicine Atracurium Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 25. Zhejiang Xianju Pharmaceutical Atracurium Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 26. Joshi & Company Atracurium Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 27. ZHEJIANG HAISEN PHARMACEUICAL Atracurium Revenue Year Over Year Growth (US$, Mn) & (2016-2021)
Figure 28. China Atracurium Production Capacity (K Pcs), 2016-2027
Figure 29. Atracurium Industry Value Chain
Figure 30. Marketing Channels
  • Global Histone Deacetylase (HDAC) Inhibitors Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 87
    The global Histone Deacetylase (HDAC) Inhibitors market was valued at US$ 615.2 million in 2023 and is anticipated to reach US$ 1223.2 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. North American market for Histone Deacetylase (HDAC) Inhibitors is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Histone Deacetylase (HDAC) Inhibitor......
  • Global Esomeprazole Magnesium Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 74
    The global Esomeprazole Magnesium market was valued at US$ 5287 million in 2023 and is anticipated to reach US$ 9451.5 million by 2030, witnessing a CAGR of 8.3% during The forecast period 2024-2030. North American market for Esomeprazole Magnesium is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Esomeprazole Magnesium is estimated to increase from $ million in 2......
  • Global Combination Therapy Drug Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86
    The global Combination Therapy Drug market was valued at US$ 105 million in 2023 and is anticipated to reach US$ 166.7 million by 2030, witnessing a CAGR of 4.1% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is......
  • Global Axitinib Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 68
    The global Axitinib market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Axitinib is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The......
  • Global Lyme Disease Vaccine Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 70
    The lyme disease vaccine can reduce lyme disease incidence, reduce symptoms and reduce mortality. Lyme disease is a tick-borne infection of spirochete, a natural disease caused by borrelia burgdorferi. The global Lyme Disease Vaccine market was valued at US$ 257 million in 2023 and is anticipated to reach US$ 763 million by 2030, witnessing a CAGR of 8.8% during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at......
  • Global Transdermal Absorption Patch Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 85
    The global Transdermal Absorption Patch market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Transdermal Absorption Patch is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Transdermal Absorption Patch is estimated to increase from $ million i......
  • Global Ketoprofen Patches Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 78
    Ketoprofen patch, indications for The treatment of symptoms caused by The following diseases: rheumatoid arthritis and rheumatoid arthritis The global Ketoprofen Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Ketoprofen Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast per......
  • Global Methyl Salicylate Patches Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 82
    The global Methyl Salicylate Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Methyl Salicylate Patches is estimated to increase from $ million in 2023 to......
  • Global Diclofenac Patches Market Research Report 2024
    Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 94
    The global Diclofenac Patches market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Diclofenac Patches is estimated to increase from $ million in 2023 to reach $ million by 2......
  • SERVICES
    Value for Money
    We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
    Ever Growing Inventory
    Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
    One Stop Solution
    Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
    Dedicated Client Engagement
    Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
    Saving Time and Efforts
    Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
    Payment Flexibility
    Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
    Post-Purchase Research Support
    Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )
    • Ad Hoc
    • Pay - as - you - go / Bucket Subscriptions
    • Fixed Cost for #of reports
    • Customize / Personalize as per your needs